Your browser doesn't support javascript.
loading
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study.
Federico, Lorenzo; Tvedt, Tor Henrik Anderson; Gainullin, Murat; Osen, Julie Røkke; Chaban, Viktoriia; Lund, Katrine Persgård; Tietze, Lisa; Tran, Trung The; Lund-Johansen, Fridtjof; Kared, Hassen; Lind, Andreas; Vaage, John Torgils; Stratford, Richard; Tennøe, Simen; Malone, Brandon; Clancy, Trevor; Myhre, Anders Eivind Leren; Gedde-Dahl, Tobias; Munthe, Ludvig André.
Afiliación
  • Federico L; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Tvedt THA; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Gainullin M; Department of Haematology, Oslo University Hospital, Oslo, Norway.
  • Osen JR; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Chaban V; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Lund KP; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Tietze L; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Tran TT; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Lund-Johansen F; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Kared H; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Lind A; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Vaage JT; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Stratford R; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Tennøe S; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Malone B; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Clancy T; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Myhre AEL; ImmunoLingo Convergence Center, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Gedde-Dahl T; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Munthe LA; KG Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Front Immunol ; 14: 1210899, 2023.
Article en En | MEDLINE | ID: mdl-37503339
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Noruega